Resumen de acción NAN
Nanosonics Limited, junto con sus filiales, opera como empresa de prevención de infecciones en Australia y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
NAN ha superado nuestros controles de riesgos.
Competidores de Nanosonics Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.91 |
| 52 Week High | AU$5.63 |
| 52 Week Low | AU$2.59 |
| Beta | 1.57 |
| 1 Month Change | 2.83% |
| 3 Month Change | -1.02% |
| 1 Year Change | -48.04% |
| 3 Year Change | -43.50% |
| 5 Year Change | -39.38% |
| Change since IPO | 254.88% |
Noticias y actualizaciones recientes
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27
Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Is Nanosonics' (ASX:NAN) Share Price Gain Of 250% Well Earned?
Jul 28Rentabilidad de los accionistas
| NAN | AU Medical Equipment | Mercado AU | |
|---|---|---|---|
| 7D | 6.2% | 2.1% | 1.8% |
| 1Y | -48.0% | 17.4% | 7.0% |
Rentabilidad vs. Industria: NAN obtuvo unos resultados inferiores a los del sector Australian Medical Equipment , que el año pasado arrojó un rendimiento del 14.7%.
Rentabilidad vs. Mercado: NAN obtuvo unos resultados inferiores a los del mercado Australian, que fue del 5.7% el año pasado.
Volatilidad de los precios
| NAN volatility | |
|---|---|
| NAN Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 10.1% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.5% |
Precio estable de las acciones: NAN no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de NAN (12%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 482 | Michael Kavanagh | www.nanosonics.com.au |
Nanosonics Limited, junto con sus filiales, opera como empresa de prevención de infecciones en Australia y a escala internacional. La empresa fabrica y distribuye el desinfectador de sonda por ultrasonidos trophon y sus consumibles y accesorios relacionados, además de investigar, desarrollar y comercializar productos de control de infecciones y descontaminación y tecnologías afines. Su cartera de productos incluye trophon2, que ofrece protección en varios niveles del ciclo de desinfección HLD; Nanosonics AuditPro, una gestión del cumplimiento del flujo de trabajo de control de infecciones; Trophon EPR, para mitigar el riesgo de exposición a sustancias químicas tóxicas; y CORIS, una plataforma de productos de reprocesamiento de instrumentos.
Resumen de fundamentos de Nanosonics Limited
| Estadísticas fundamentales de NAN | |
|---|---|
| Capitalización bursátil | AU$887.73m |
| Beneficios(TTM) | AU$15.68m |
| Ingresos (TTM) | AU$164.07m |
56.2x
Ratio precio-beneficio (PE)5.4x
Ratio precio-ventas (PS)¿Está NAN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NAN | |
|---|---|
| Ingresos | AU$164.07m |
| Coste de los ingresos | AU$34.34m |
| Beneficio bruto | AU$129.73m |
| Otros gastos | AU$114.04m |
| Beneficios | AU$15.68m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.052 |
| Margen bruto | 79.07% |
| Margen de beneficio neto | 9.56% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado NAN a largo plazo?
Ver rendimiento histórico y comparativa